SCHEMBL24199367

SCHEMBL24199367

Fc1ccc(SCI)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
ALDH1A1 P00352 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
CRBN Q96SW2 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
DAO P14920 1/20 0.36
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
IDO1 P14902 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL778040 0.78 MAOA (0.45) MAOAMAOBALDH1A1NPC1RAB9A
SCHEMBL14303351 0.76 MAOA (0.44) MAOAMAOBALDH1A1L3MBTL1NPC1
SCHEMBL14666345 0.74 KMT2A (0.47) MAOAMAOBALDH1A1L3MBTL1NPC1
SCHEMBL642607 0.74 SLC6A4 (0.47) MAOAMAOBALDH1A1POLBLMNA
SCHEMBL10734601 0.74 MAOA (0.42) MAOAMAOBALDH1A1L3MBTL1NPC1
SCHEMBL14666343 0.74 RAB9A (0.45) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL15013797 0.74 HTR1A (0.47) MAOAMAOBALDH1A1LMNAHTT
SCHEMBL1739588 0.74 MAOA (0.42) MAOAMAOBALDH1A1L3MBTL1NPC1
SCHEMBL2558169 0.73 MAOA (0.39) MAOAMAOBALDH1A1L3MBTL1NPC1
SCHEMBL23182802 0.73 GRM2 (0.35) MAOAMAOBALDH1A1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 MAOA 2295/4885MAOB 2175/4885ALDH1A1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.